Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-13 4:56 pm Sale | 2026-09-30 | 13G | YARROW BIOSCIENCE, INC. YARW | Nantahala Capital Management, LLC | 39,198 0.460% | -802 (-2.00%) | Filing History |
| 2026-11-13 4:04 pm Purchase | 2026-09-30 | 13G | YARROW BIOSCIENCE, INC. YARW | Spruce Street Capital LP | 607,382 6.400% | 607,382 (New Position) | Filing History |
| 2026-10-07 12:41 pm Purchase | 2026-09-10 | 13G | YARROW BIOSCIENCE, INC. YARW | Bellevue Group AG | 1,000,000 10.600% | 1,000,000 (New Position) | Filing History |
| 2026-09-17 4:57 pm Purchase | 2026-09-11 | 13G | YARROW BIOSCIENCE, INC. YARW | Invus Public Equities, L.P. | 675,000 7.200% | 675,000 (New Position) | Filing History |
| 2026-08-14 9:32 pm Purchase | 2026-06-30 | 13G | YARROW BIOSCIENCE, INC. YARW | ADAR1 Capital Management LLC | 59,000 8.800% | 59,000 (New Position) | Filing History |
| 2026-08-14 4:34 pm Purchase | 2026-07-27 | 13G | YARROW BIOSCIENCE, INC. YARW | venBio Global Strategic Fund V, L.P. | 279,340 9.990% | 279,340 (New Position) | Filing History |
| 2026-08-13 10:00 am Purchase | 2026-08-13 | 13G | YARROW BIOSCIENCE, INC. YARW | Zhang Xiaofan | 162,452 0.600% | 162,452 (New Position) | Filing History |
| 2026-08-07 7:51 pm Purchase | 2026-07-31 | 13G | YARROW BIOSCIENCE, INC. YARW | Logos Global Management LP | 286,308 10.700% | 9,604 (+3.47%) | Filing History |
| 2026-08-07 12:51 pm Purchase | 2026-07-31 | 13G | YARROW BIOSCIENCE, INC. YARW | JANUS HENDERSON GROUP Ltd. JHG | 266,712 9.990% | 266,712 (New Position) | Filing History |
| 2026-08-05 9:08 pm Purchase | 2026-07-27 | 13D | YARROW BIOSCIENCE, INC. YARW | ORBIMED ADVISORS LLC | 266,306 9.970% | 266,306 (New Position) | Filing History |
| 2026-08-04 2:12 pm Purchase | 2026-07-27 | 13G | YARROW BIOSCIENCE, INC. YARW | Logos Global Management LP | 276,704 9.900% | 276,704 (New Position) | Filing History |
| 2026-08-03 4:00 pm Purchase | 2026-07-27 | 13G | YARROW BIOSCIENCE, INC. YARW | Perceptive Advisors LLC | 266,756 9.990% | 264,061 (+9798.18%) | Filing History |
| 2026-07-30 4:06 pm Purchase | 2026-07-27 | 13G | YARROW BIOSCIENCE, INC. YARW | RTW Fund Group GP, LLC | 266,307 9.990% | 266,307 (New Position) | Filing History |
| 2026-07-29 4:06 pm Sale | 2026-07-27 | 13D | YARROW BIOSCIENCE, INC. YARW | AI Biotechnology LLC | 178,180 6.020% | -3,023,800 (-94.44%) | Filing History |
| 2026-07-17 09:54 am Unchanged | 2026-06-08 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Zhang Xiaofan | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-07-14 10:06 am Sale | 2026-07-13 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Zhang Xiaofan | 0 0.000% | -37,468 (Position Closed) | Filing History |
| 2026-06-15 2:24 pm Purchase | 2026-06-08 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Zhang Xiaofan | 37,468 5.600% | 37,468 (New Position) | Filing History |
| 2026-05-15 4:35 pm Purchase | 2026-03-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Nantahala Capital Management, LLC | 40,000 6.000% | 40,000 (New Position) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Citadel Advisors LLC | 75 0.000% | -21,932 (-99.66%) | Filing History |
| 2025-11-14 3:23 pm Sale | 2025-09-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Eventide Asset Management, LLC | 0 0.000% | -36,992 (Position Closed) | Filing History |